AB0637 Markers of Endothelial Inflammation and Repair in a Group of Patients with Systemic Vasculitis

BackgroundThe role of the endothelium as an active player rather than a passive victim of inflammation has received considerable interest in systemic vasculitis 1. Local vascular inflammation can have distant effects on the systemic vascular system, leading to widespread endothelial cell dysfunction...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2015-06, Vol.74 (Suppl 2), p.1112
Hauptverfasser: Kalinova, D., Todorova, E., Velikova, T., Tumangelova-Yuzeir, K., Parvova, I., Kyurkchiev, D., Rashkov, R.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Suppl 2
container_start_page 1112
container_title Annals of the rheumatic diseases
container_volume 74
creator Kalinova, D.
Todorova, E.
Velikova, T.
Tumangelova-Yuzeir, K.
Parvova, I.
Kyurkchiev, D.
Rashkov, R.
description BackgroundThe role of the endothelium as an active player rather than a passive victim of inflammation has received considerable interest in systemic vasculitis 1. Local vascular inflammation can have distant effects on the systemic vascular system, leading to widespread endothelial cell dysfunction 2. Damage to endothelial cells and developed vascular endothelial dysfunction are crucial events during the pathogenesis of vasculitis. The mechanisms that drive such endothelial dysfunction are unclear but factors such as adhesion molecules, chemokines, inflammatory cells, and different cytokines may play a role. One of the adaptive responses to this injury is the migration of hemopoetic stem cells from the bone marrow to sites of endothelial injury under the control of serum cytokines and growth factors3.ObjectivesThe objectives of the study were to examine some serum markers of inflammation (adhesion molecules – sICAM-1, sPECAM; cytokines - IL-10, IL-8, TNFα) and activated T helpers and hemopoetic stem cells in patients with active vasculitis and healthy controls.MethodsWe performed a longitudinal study of 32 patients with vasculitis and 30 healthy age-matched controls. The group of vasculitis consisted of 18 patients with ANCA negative vasculitis, developed in the course of systemic connective tissue disease and 14 patients with ANCA-associated vasculitis. The vasculitis subtype was classified using the Chapel Hill Consensus Conference (CHCC) criteria and/or the American College of Rheumatology (ACR) classification criteria. Serum levels of sICAM-1, sPECAM, IL-10, IL-8, TNFα were measured by sandwich enzyme-linked immunosorbent assay (ELISA). For the detection of activated T helpers (CD3+CD4+CD69) and hemopoetic CD45+CD34+ stem cells we used flow cytometry. Statistical analyses were performed with SPSS 19.0, it was used unpaired and paired two sample Students's t-test.ResultsLevels of sPECAM and IL-8 were significantly higher in patients with vasculitis than in healthy controls (p=0.028, respectively p=0.002). We also found statistically significant increased percentage of CD3+CD4+CD69+ T helper cells in patients (p0.05).ConclusionsWe have demonstrated changes in some biomarkers of inflammation in patients with active va
doi_str_mv 10.1136/annrheumdis-2015-eular.3092
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1901786600</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4322503685</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1270-4ffea4c7aba40c505d81dad2617bc1711486933990648593be3215c3b265d4903</originalsourceid><addsrcrecordid>eNqVkL9OwzAQhy0EEqXwDpY6p5xjx4nFVKpSKhWB-LdaTuJQl8QJdiLUjYUX5UlIKAMr0-l3d9-d9CE0ITAlhPJzZa3b6K7KjQ9CIFGgu1K5KQURHqARYTzp2xwO0QgAaMAEj4_RiffbPkJCkhF6mV0Cp_HXx-eNcq_aeVwXeGHzut3o0qgSr2xRqqpSraktVjbH97pRxmHTJ7x0ddcMxF0_17b1-N20G_yw862uTIaflc-60rTGn6KjQpVen_3WMXq6WjzOr4P17XI1n62DlIQxBKwotGJZrFLFIIsgyhOSqzzkJE4zEhPCEi4oFQI4SyJBU01DEmU0DXmUMwF0jCb7u42r3zrtW7mtO2f7l5IIIHHCOQxbF_utzNXeO13IxplKuZ0kIAez8o9ZOZiVP2blYLan-Z5Oq-2_wG87KoSL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1901786600</pqid></control><display><type>article</type><title>AB0637 Markers of Endothelial Inflammation and Repair in a Group of Patients with Systemic Vasculitis</title><source>BMJ Journals - NESLi2</source><creator>Kalinova, D. ; Todorova, E. ; Velikova, T. ; Tumangelova-Yuzeir, K. ; Parvova, I. ; Kyurkchiev, D. ; Rashkov, R.</creator><creatorcontrib>Kalinova, D. ; Todorova, E. ; Velikova, T. ; Tumangelova-Yuzeir, K. ; Parvova, I. ; Kyurkchiev, D. ; Rashkov, R.</creatorcontrib><description>BackgroundThe role of the endothelium as an active player rather than a passive victim of inflammation has received considerable interest in systemic vasculitis 1. Local vascular inflammation can have distant effects on the systemic vascular system, leading to widespread endothelial cell dysfunction 2. Damage to endothelial cells and developed vascular endothelial dysfunction are crucial events during the pathogenesis of vasculitis. The mechanisms that drive such endothelial dysfunction are unclear but factors such as adhesion molecules, chemokines, inflammatory cells, and different cytokines may play a role. One of the adaptive responses to this injury is the migration of hemopoetic stem cells from the bone marrow to sites of endothelial injury under the control of serum cytokines and growth factors3.ObjectivesThe objectives of the study were to examine some serum markers of inflammation (adhesion molecules – sICAM-1, sPECAM; cytokines - IL-10, IL-8, TNFα) and activated T helpers and hemopoetic stem cells in patients with active vasculitis and healthy controls.MethodsWe performed a longitudinal study of 32 patients with vasculitis and 30 healthy age-matched controls. The group of vasculitis consisted of 18 patients with ANCA negative vasculitis, developed in the course of systemic connective tissue disease and 14 patients with ANCA-associated vasculitis. The vasculitis subtype was classified using the Chapel Hill Consensus Conference (CHCC) criteria and/or the American College of Rheumatology (ACR) classification criteria. Serum levels of sICAM-1, sPECAM, IL-10, IL-8, TNFα were measured by sandwich enzyme-linked immunosorbent assay (ELISA). For the detection of activated T helpers (CD3+CD4+CD69) and hemopoetic CD45+CD34+ stem cells we used flow cytometry. Statistical analyses were performed with SPSS 19.0, it was used unpaired and paired two sample Students's t-test.ResultsLevels of sPECAM and IL-8 were significantly higher in patients with vasculitis than in healthy controls (p=0.028, respectively p=0.002). We also found statistically significant increased percentage of CD3+CD4+CD69+ T helper cells in patients (p&lt;0.001). No significant difference was found between both groups for TNFα, IL-10 and sICAM levels. The percentage of CD45+CD34+ hemopoetic stem cells was higher in healthy controls than in patients, as the difference was no significantly (p&gt;0.05).ConclusionsWe have demonstrated changes in some biomarkers of inflammation in patients with active vasculitis. The study of different biomarkers provides an opportunity to investigate the pathogenesis of vascular inflammation, which could be used for clinical monitoring of vasculitis.ReferencesBacon P. Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects. Curr Opin Rheum 2005, 17: 49-55.Buckley C. Endothelail cells, fibroblast and vasculitis. Rheumatology 2005, 44: 860-863.Clarke L et al. Endothelail injury and repair in systemic vasculitis of the young. Arth Rheum 2010, 62: 1770-1780.Disclosure of InterestNone declared</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2015-eular.3092</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>Kidlington: Elsevier Limited</publisher><ispartof>Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1112</ispartof><rights>2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2015 (c) 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/74/Suppl_2/1112.1.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/74/Suppl_2/1112.1.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,777,781,3183,23552,27905,27906,77349,77380</link.rule.ids></links><search><creatorcontrib>Kalinova, D.</creatorcontrib><creatorcontrib>Todorova, E.</creatorcontrib><creatorcontrib>Velikova, T.</creatorcontrib><creatorcontrib>Tumangelova-Yuzeir, K.</creatorcontrib><creatorcontrib>Parvova, I.</creatorcontrib><creatorcontrib>Kyurkchiev, D.</creatorcontrib><creatorcontrib>Rashkov, R.</creatorcontrib><title>AB0637 Markers of Endothelial Inflammation and Repair in a Group of Patients with Systemic Vasculitis</title><title>Annals of the rheumatic diseases</title><description>BackgroundThe role of the endothelium as an active player rather than a passive victim of inflammation has received considerable interest in systemic vasculitis 1. Local vascular inflammation can have distant effects on the systemic vascular system, leading to widespread endothelial cell dysfunction 2. Damage to endothelial cells and developed vascular endothelial dysfunction are crucial events during the pathogenesis of vasculitis. The mechanisms that drive such endothelial dysfunction are unclear but factors such as adhesion molecules, chemokines, inflammatory cells, and different cytokines may play a role. One of the adaptive responses to this injury is the migration of hemopoetic stem cells from the bone marrow to sites of endothelial injury under the control of serum cytokines and growth factors3.ObjectivesThe objectives of the study were to examine some serum markers of inflammation (adhesion molecules – sICAM-1, sPECAM; cytokines - IL-10, IL-8, TNFα) and activated T helpers and hemopoetic stem cells in patients with active vasculitis and healthy controls.MethodsWe performed a longitudinal study of 32 patients with vasculitis and 30 healthy age-matched controls. The group of vasculitis consisted of 18 patients with ANCA negative vasculitis, developed in the course of systemic connective tissue disease and 14 patients with ANCA-associated vasculitis. The vasculitis subtype was classified using the Chapel Hill Consensus Conference (CHCC) criteria and/or the American College of Rheumatology (ACR) classification criteria. Serum levels of sICAM-1, sPECAM, IL-10, IL-8, TNFα were measured by sandwich enzyme-linked immunosorbent assay (ELISA). For the detection of activated T helpers (CD3+CD4+CD69) and hemopoetic CD45+CD34+ stem cells we used flow cytometry. Statistical analyses were performed with SPSS 19.0, it was used unpaired and paired two sample Students's t-test.ResultsLevels of sPECAM and IL-8 were significantly higher in patients with vasculitis than in healthy controls (p=0.028, respectively p=0.002). We also found statistically significant increased percentage of CD3+CD4+CD69+ T helper cells in patients (p&lt;0.001). No significant difference was found between both groups for TNFα, IL-10 and sICAM levels. The percentage of CD45+CD34+ hemopoetic stem cells was higher in healthy controls than in patients, as the difference was no significantly (p&gt;0.05).ConclusionsWe have demonstrated changes in some biomarkers of inflammation in patients with active vasculitis. The study of different biomarkers provides an opportunity to investigate the pathogenesis of vascular inflammation, which could be used for clinical monitoring of vasculitis.ReferencesBacon P. Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects. Curr Opin Rheum 2005, 17: 49-55.Buckley C. Endothelail cells, fibroblast and vasculitis. Rheumatology 2005, 44: 860-863.Clarke L et al. Endothelail injury and repair in systemic vasculitis of the young. Arth Rheum 2010, 62: 1770-1780.Disclosure of InterestNone declared</description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqVkL9OwzAQhy0EEqXwDpY6p5xjx4nFVKpSKhWB-LdaTuJQl8QJdiLUjYUX5UlIKAMr0-l3d9-d9CE0ITAlhPJzZa3b6K7KjQ9CIFGgu1K5KQURHqARYTzp2xwO0QgAaMAEj4_RiffbPkJCkhF6mV0Cp_HXx-eNcq_aeVwXeGHzut3o0qgSr2xRqqpSraktVjbH97pRxmHTJ7x0ddcMxF0_17b1-N20G_yw862uTIaflc-60rTGn6KjQpVen_3WMXq6WjzOr4P17XI1n62DlIQxBKwotGJZrFLFIIsgyhOSqzzkJE4zEhPCEi4oFQI4SyJBU01DEmU0DXmUMwF0jCb7u42r3zrtW7mtO2f7l5IIIHHCOQxbF_utzNXeO13IxplKuZ0kIAez8o9ZOZiVP2blYLan-Z5Oq-2_wG87KoSL</recordid><startdate>201506</startdate><enddate>201506</enddate><creator>Kalinova, D.</creator><creator>Todorova, E.</creator><creator>Velikova, T.</creator><creator>Tumangelova-Yuzeir, K.</creator><creator>Parvova, I.</creator><creator>Kyurkchiev, D.</creator><creator>Rashkov, R.</creator><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>201506</creationdate><title>AB0637 Markers of Endothelial Inflammation and Repair in a Group of Patients with Systemic Vasculitis</title><author>Kalinova, D. ; Todorova, E. ; Velikova, T. ; Tumangelova-Yuzeir, K. ; Parvova, I. ; Kyurkchiev, D. ; Rashkov, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1270-4ffea4c7aba40c505d81dad2617bc1711486933990648593be3215c3b265d4903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kalinova, D.</creatorcontrib><creatorcontrib>Todorova, E.</creatorcontrib><creatorcontrib>Velikova, T.</creatorcontrib><creatorcontrib>Tumangelova-Yuzeir, K.</creatorcontrib><creatorcontrib>Parvova, I.</creatorcontrib><creatorcontrib>Kyurkchiev, D.</creatorcontrib><creatorcontrib>Rashkov, R.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kalinova, D.</au><au>Todorova, E.</au><au>Velikova, T.</au><au>Tumangelova-Yuzeir, K.</au><au>Parvova, I.</au><au>Kyurkchiev, D.</au><au>Rashkov, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AB0637 Markers of Endothelial Inflammation and Repair in a Group of Patients with Systemic Vasculitis</atitle><jtitle>Annals of the rheumatic diseases</jtitle><date>2015-06</date><risdate>2015</risdate><volume>74</volume><issue>Suppl 2</issue><spage>1112</spage><pages>1112-</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>BackgroundThe role of the endothelium as an active player rather than a passive victim of inflammation has received considerable interest in systemic vasculitis 1. Local vascular inflammation can have distant effects on the systemic vascular system, leading to widespread endothelial cell dysfunction 2. Damage to endothelial cells and developed vascular endothelial dysfunction are crucial events during the pathogenesis of vasculitis. The mechanisms that drive such endothelial dysfunction are unclear but factors such as adhesion molecules, chemokines, inflammatory cells, and different cytokines may play a role. One of the adaptive responses to this injury is the migration of hemopoetic stem cells from the bone marrow to sites of endothelial injury under the control of serum cytokines and growth factors3.ObjectivesThe objectives of the study were to examine some serum markers of inflammation (adhesion molecules – sICAM-1, sPECAM; cytokines - IL-10, IL-8, TNFα) and activated T helpers and hemopoetic stem cells in patients with active vasculitis and healthy controls.MethodsWe performed a longitudinal study of 32 patients with vasculitis and 30 healthy age-matched controls. The group of vasculitis consisted of 18 patients with ANCA negative vasculitis, developed in the course of systemic connective tissue disease and 14 patients with ANCA-associated vasculitis. The vasculitis subtype was classified using the Chapel Hill Consensus Conference (CHCC) criteria and/or the American College of Rheumatology (ACR) classification criteria. Serum levels of sICAM-1, sPECAM, IL-10, IL-8, TNFα were measured by sandwich enzyme-linked immunosorbent assay (ELISA). For the detection of activated T helpers (CD3+CD4+CD69) and hemopoetic CD45+CD34+ stem cells we used flow cytometry. Statistical analyses were performed with SPSS 19.0, it was used unpaired and paired two sample Students's t-test.ResultsLevels of sPECAM and IL-8 were significantly higher in patients with vasculitis than in healthy controls (p=0.028, respectively p=0.002). We also found statistically significant increased percentage of CD3+CD4+CD69+ T helper cells in patients (p&lt;0.001). No significant difference was found between both groups for TNFα, IL-10 and sICAM levels. The percentage of CD45+CD34+ hemopoetic stem cells was higher in healthy controls than in patients, as the difference was no significantly (p&gt;0.05).ConclusionsWe have demonstrated changes in some biomarkers of inflammation in patients with active vasculitis. The study of different biomarkers provides an opportunity to investigate the pathogenesis of vascular inflammation, which could be used for clinical monitoring of vasculitis.ReferencesBacon P. Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects. Curr Opin Rheum 2005, 17: 49-55.Buckley C. Endothelail cells, fibroblast and vasculitis. Rheumatology 2005, 44: 860-863.Clarke L et al. Endothelail injury and repair in systemic vasculitis of the young. Arth Rheum 2010, 62: 1770-1780.Disclosure of InterestNone declared</abstract><cop>Kidlington</cop><pub>Elsevier Limited</pub><doi>10.1136/annrheumdis-2015-eular.3092</doi></addata></record>
fulltext fulltext
identifier ISSN: 0003-4967
ispartof Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1112
issn 0003-4967
1468-2060
language eng
recordid cdi_proquest_journals_1901786600
source BMJ Journals - NESLi2
title AB0637 Markers of Endothelial Inflammation and Repair in a Group of Patients with Systemic Vasculitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T08%3A18%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AB0637%E2%80%85Markers%20of%20Endothelial%20Inflammation%20and%20Repair%20in%20a%20Group%20of%20Patients%20with%20Systemic%20Vasculitis&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Kalinova,%20D.&rft.date=2015-06&rft.volume=74&rft.issue=Suppl%202&rft.spage=1112&rft.pages=1112-&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/annrheumdis-2015-eular.3092&rft_dat=%3Cproquest_cross%3E4322503685%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1901786600&rft_id=info:pmid/&rfr_iscdi=true